{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:21:54Z","timestamp":1792167714940,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1245\/s10434-025-17420-8","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T16:20:23Z","timestamp":1746807623000},"page":"5928-5935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Postoperative Recurrence Pattern of Clinical Stage I Esophageal Cancer After Esophagectomy with Two- or Three-Field Lymph Node Dissection: Supplementary Analysis from JCOG0502"],"prefix":"10.1245","volume":"32","author":[{"given":"Takeo","family":"Bamba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Daiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryunosuke","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"17420_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin."},{"key":"17420_CR2","doi-asserted-by":"crossref","unstructured":"Watanabe M, Toh Y, Ishihara R, et al. Registration committee for esophageal cancer of the Japan Esophageal Society. comprehensive registry of esophageal cancer in Japan, 2015. Esophagus. 2023;20:1\u201328.","DOI":"10.1007\/s10388-022-00950-5"},{"key":"17420_CR3","doi-asserted-by":"crossref","unstructured":"Rice TW, Rusch VW, Ishwaran H, Blackstone EH. Worldwide Esophageal Cancer Collaboration. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer\/International Union Against Cancer Cancer Staging Manuals. Cancer. 2010;116:3763\u201373.","DOI":"10.1002\/cncr.25146"},{"key":"17420_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10388-023-00993-2","volume":"20","author":"Y Kitagawa","year":"2023","unstructured":"Kitagawa Y, Ishihara R, Ishikawa H, et al. Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 1. Esophagus. 2023;20:343\u201372.","journal-title":"Esophagus."},{"key":"17420_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.athoracsur.2021.10.021","volume":"114","author":"C Chang","year":"2022","unstructured":"Chang C, Linden PA, Jiang B, et al. Monitoring for recurrence after esophagectomy. Ann Thorac Surg. 2022;114:211\u20137.","journal-title":"Ann Thorac Surg."},{"key":"17420_CR6","doi-asserted-by":"crossref","unstructured":"Kato K, Ito Y, Nozaki I, et al. Japan Esophageal Oncology Group of the Japan Clinical Oncology Group. Parallel-group controlled trial of surgery versus chemoradiotherapy in patients with stage I esophageal squamous cell carcinoma. Gastroenterology. 2021;161:1878\u201386.","DOI":"10.1053\/j.gastro.2021.08.007"},{"key":"17420_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10388-009-0221-0","volume":"7","author":"Y Toh","year":"2010","unstructured":"Toh Y, Oki E, Minami K, Okamura T. Follow-up and recurrence after a curative esophagectomy for patients with esophageal cancer: the first indicators for recurrence and their prognostic values. Esophagus. 2010;7:37\u201343.","journal-title":"Esophagus."},{"key":"17420_CR8","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1245\/s10434-011-1747-7","volume":"18","author":"H Miyata","year":"2011","unstructured":"Miyata H, Yamasaki M, Kurokawa Y, et al. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Ann Surg Oncol. 2011;18:3353\u201361.","journal-title":"Ann Surg Oncol."},{"key":"17420_CR9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3892\/mco.2015.688","volume":"4","author":"I Ninomiya","year":"2016","unstructured":"Ninomiya I, Okamoto K, Tsukada T, et al. Recurrence patterns and risk factors following thoracoscopic esophagectomy with radical lymph node dissection for thoracic esophageal squamous cell carcinoma. Mol Clin Oncol. 2016;4:278\u201384.","journal-title":"Mol Clin Oncol."},{"key":"17420_CR10","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00268-017-4024-5","volume":"41","author":"K Yamashita","year":"2017","unstructured":"Yamashita K, Watanabe M, Mine S, et al. Patterns and outcomes of recurrent esophageal cancer after curative esophagectomy. World J Surg. 2017;41:2337\u201344.","journal-title":"World J Surg."},{"key":"17420_CR11","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.athoracsur.2016.03.117","volume":"102","author":"CH Kang","year":"2016","unstructured":"Kang CH, Hwang Y, Lee HJ, Park IK, Kim YT. Risk factors for local recurrence and optimal length of esophagectomy in esophageal squamous cell carcinoma. Ann Thorac Surg. 2016;102:1074\u201380.","journal-title":"Ann Thorac Surg."},{"key":"17420_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2152\/jmi.68.129","volume":"68","author":"M Sohda","year":"2021","unstructured":"Sohda M, Yoshida T, Nakazawa N, et al. Comparative study on recurrence pattern and treatment method after radical esophagectomy for esophageal cancer. J Med Invest. 2021;68:129\u201335.","journal-title":"J Med Invest."},{"key":"17420_CR13","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1245\/s10434-012-2231-8","volume":"19","author":"M Motoori","year":"2012","unstructured":"Motoori M, Yano M, Ishihara R, et al. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer. Ann Surg Oncol. 2012;19:2135\u201341.","journal-title":"Ann Surg Oncol."},{"key":"17420_CR14","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00268-016-3454-9","volume":"40","author":"Y Ozawa","year":"2016","unstructured":"Ozawa Y, Kamei T, Nakano T, Taniyama Y, Miyagi S, Ohuchi N. Characteristics of postoperative recurrence in lymph node-negative superficial esophageal carcinoma. World J Surg. 2016;40:1663\u201371.","journal-title":"World J Surg."},{"key":"17420_CR15","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1245\/s10434-013-3372-0","volume":"21","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Matono S, Mori N, Shirouzu K, Fujita H. T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy. Ann Surg Oncol. 2014;21:932\u20138.","journal-title":"Ann Surg Oncol."},{"key":"17420_CR16","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/SLA.0b013e318163a2ff","volume":"247","author":"NK Altorki","year":"2008","unstructured":"Altorki NK, Lee PC, Liss Y, et al. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Ann Surg. 2008;247:434\u20139.","journal-title":"Ann Surg."},{"key":"17420_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1245\/s10434-011-2023-6","volume":"19","author":"T Tanaka","year":"2012","unstructured":"Tanaka T, Matono S, Nagano T, Shirouzu K, Fujita H, Yamana H. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors. Ann Surg Oncol. 2012;19:750\u20136.","journal-title":"Ann Surg Oncol."},{"key":"17420_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1245\/s10434-007-9604-4","volume":"15","author":"M Tachibana","year":"2008","unstructured":"Tachibana M, Hirahara N, Kinugasa S, Yoshimura H. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients. Ann Surg Oncol. 2008;15:104\u201316.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"17420_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13019-014-0150-4","volume":"28","author":"XF Guo","year":"2014","unstructured":"Guo XF, Mao T, Gu ZT, Ji CY, Fang WT, Chen WH. Clinical study on postoperative recurrence in patients with pN0 esophageal squamous cell carcinoma. J Cardiothorac Surg. 2014;28(9):150.","journal-title":"J Cardiothorac Surg."},{"key":"17420_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10388-015-0511-7","volume":"13","author":"Y Toh","year":"2016","unstructured":"Toh Y, Kitagawa Y, Kuwano H, et al. A nation-wide survey of follow-up strategies for esophageal cancer patients after a curative esophagectomy or a complete response by definitive chemoradiotherapy in Japan. Esophagus. 2016;13:173\u201381.","journal-title":"Esophagus."},{"key":"17420_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13019-019-0883-1","volume":"14","author":"G Lin","year":"2019","unstructured":"Lin G, Liu H, Li J. Pattern of recurrence and prognostic factors in patients with pT1-3 N0 esophageal squamous cell carcinoma after surgery: analysis of a single-center experience. J Cardiothorac Surg. 2019;14:58.","journal-title":"J Cardiothorac Surg."},{"key":"17420_CR22","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jtcvs.2013.01.034","volume":"146","author":"D Situ","year":"2013","unstructured":"Situ D, Wang J, Lin P, et al. Do tumor location and grade affect survival in pT2N0M0 esophageal squamous cell carcinoma? J Thorac Cardiovasc Surg. 2013;146:45\u201351.","journal-title":"J Thorac Cardiovasc Surg."},{"key":"17420_CR23","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s00268-005-7596-4","volume":"29","author":"Y Doki","year":"2005","unstructured":"Doki Y, Ishikawa O, Takachi K, et al. Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma. World J Surg. 2005;29:700\u20137.","journal-title":"World J Surg."},{"key":"17420_CR24","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1245\/s10434-019-07499-1","volume":"26","author":"Y Koterazawa","year":"2019","unstructured":"Koterazawa Y, Oshikiri T, Takiguchi G, et al. Prophylactic cervical lymph node dissection in thoracoscopic esophagectomy for esophageal cancer increases postoperative complications and does not improve survival. Ann Surg Oncol. 2019;26:2899\u2013904.","journal-title":"Ann Surg Oncol."},{"key":"17420_CR25","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.athoracsur.2013.06.050","volume":"96","author":"T Ye","year":"2013","unstructured":"Ye T, Sun Y, Zhang Y, Zhang Y, Chen H. Three-field or two-field resection for thoracic esophageal cancer: a meta-analysis. Ann Thorac Surg. 2013;96:1933\u201341.","journal-title":"Ann Thorac Surg."},{"key":"17420_CR26","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1245\/s10434-014-4008-8","volume":"22","author":"X Ma","year":"2015","unstructured":"Ma X, Zhao K, Guo W, et al. Salvage lymphadenectomy versus salvage radiotherapy\/chemoradiotherapy for recurrence in cervical lymph node after curative resection of esophageal squamous cell carcinoma. Ann Surg Oncol. 2015;22:624\u20139.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17420-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17420-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17420-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:58:44Z","timestamp":1751464724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17420-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["17420"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17420-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Takeshi Kajiwara received honoraria for lectures from Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Bristol-Myers Squibb K.K., Taiho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., and Daiichi Sankyo Co., Ltd. Yuko Kitagawa received honoraria from Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., Tsumura & Co., Eisai Co., Ltd., Takeda Pharmaceutical Co., Ltd., Kaken Pharmaceutical Co., Ltd., Sumitomo Pharma Co., Ltd., Otsuka Pharmaceutical Factory Inc., Kyouwa Hakkou Kirin Co., Ltd., Teijin Pharma Ltd., Kowa Company, Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}